InMed Pharmaceuticals (INM) Return on Sales Growth (1y) (2022 - 2025)
InMed Pharmaceuticals (INM) Return on Sales Growth (1y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.24 Bn | 87.37 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.17 Bn | 1.97 Bn | 0.00 |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn | 0.00 |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn | -1.00 |
| 5 | United Therapeutics | 23.28 Bn | 21.13 Bn | 648.10 Mn | 0.00 |
| 6 | RedHill Biopharma | 20.54 Bn | 20.54 Bn | - | - |
| 7 | Viatris | 20.31 Bn | 18.50 Bn | 1.16 Bn | 1.00 |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 0.00 |
| 9 | Elanco Animal Health | 12.55 Bn | 12.12 Bn | 785.00 Mn | 0.00 |
| 10 | InMed Pharmaceuticals | 7.04 Mn | 1.80 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 1.00 |
| Mar 31, 2025 | 1.00 |
| Dec 31, 2024 | -1.00 |
| Sep 30, 2024 | 1.00 |
| Jun 30, 2024 | -1.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 3.00 |
| Sep 30, 2023 | 8.00 |
| Jun 30, 2023 | 15.00 |
| Mar 31, 2023 | 4.00 |
| Dec 31, 2022 | 12.00 |